MDGL
Madrigal Pharmaceuticals, Inc.Company with tickers: MDGL
CIK
1157601
CUSIP
558868105
Shares Outstanding
23,055,659
13F Activity (30d)
220 filings
218 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| 8-K | 2026-04-28 | 2026-04-22 | |
| 10-K | 2026-02-19 | 2025-12-31 | |
| 8-K | 2026-02-19 | — | |
| 8-K | 2026-01-30 | 2026-01-29 | |
| 8-K | 2025-12-11 | 2025-12-05 | |
| 8-K | 2025-11-04 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-08-05 | — | |
| 8-K | 2025-07-30 | — | |
| 8-K | 2025-07-22 | 2025-07-17 | |
| 8-K | 2025-06-20 | — | |
| 8-K | 2025-05-01 | — | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| 8-K | 2025-04-17 | 2025-04-16 | |
| 8-K | 2025-03-11 | 2025-03-09 | |
| 10-K | 2025-02-26 | 2024-12-31 | |
| 8-K | 2025-02-26 | — | |
| 8-K | 2025-01-13 | — | |
| 10-Q | 2024-10-31 | 2024-09-30 | |
| 8-K | 2024-10-31 | — | |
| 8-K | 2024-08-07 | — | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-06-27 | 2024-06-25 | |
| 8-K | 2024-05-07 | — | |
| 10-Q | 2024-05-07 | 2024-03-31 | |
| 8-K | 2024-04-02 | 2024-03-27 | |
| 8-K | 2024-03-20 | 2024-03-18 | |
| 8-K | 2024-03-15 | 2024-03-14 | |
| 8-K | 2024-02-28 | 2024-02-22 | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-02-28 | — | |
| 8-K | 2024-01-08 | — | |
| 8-K | 2023-11-06 | — | |
| 10-Q | 2023-11-06 | 2023-09-30 | |
| 8-K | 2023-10-02 | 2023-09-28 | |
| 8-K | 2023-09-25 | 2023-09-20 | |
| 8-K | 2023-09-14 | 2023-09-08 | |
| 8-K | 2023-09-13 | 2023-09-12 | |
| 8-K | 2023-09-13 | 2023-09-07 | |
| 10-Q | 2023-08-08 | 2023-06-30 | |
| 8-K | 2023-08-08 | — | |
| 8-K | 2023-07-17 | — | |
| 8-K | 2023-06-30 | — | |
| 8-K | 2023-06-20 | 2023-06-15 | |
| 10-Q | 2023-05-09 | 2023-03-31 | |
| 8-K | 2023-05-09 | — | |
| 10-K/A | 2023-03-03 | 2022-12-31 |
Showing 1–50 of 85 filings